Cornell’s Research
Serves the Region and Beyond

TeraPore Technologies, Inc. CTL

R&D: Biotechnology

TeraPore Technologies is a venture-backed company that is commercializing cutting-edge membrane technologies. Its mission is to solve the most challenging bioseparation problems through the development and use of high-permeability, high-resolution membrane nanofiltration systems for bioprocessing and other applications across a wide range of industries. TeraPore develops and manufactures filters through a proprietary and scalable block copolymer self-assembly technology. When fabricated into membranes, the polymers spontaneously form into highly uniform structures, creating precise holes (or pores) on the nanoscale. The benefits of these membranes include high permeability, allowing very fast flow rates, and uniform pore sizes for extremely precise nanofiltration. TeraPore’s engineered membranes are manufactured at scale and at a range of different pore sizes. One critical application for TeraPore’s technology is in the production process of biological drugs (or biologics) where a key step is the separation of viral contaminants from the drug material. Beyond the biotech industry, TeraPore’s products have utility in water treatment, semiconductor processing, and responsive fabrics. The company has received support from the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Defense Threat Reduction Agency (DTRA).

Cornell Connection

The company's technology was developed at Cornell by a professor and a PhD student in the Department of Materials Science and Engineering. TeraPore's foundational technology is licensed from Cornell University.